Scinai Immunotherapeutics Ltd ADRSCNI
Price$1.31

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 31 Dec 2025
Market Price $1.31Price as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 12.7%
Volatility vs market (adjusted beta)1.72

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetScinai Immunotherapeutics Ltd ADRSCNIHealth Care
Valuation
P/E—
P/S0.8×
P/B1,798.1×
EV / Revenue5.7×
EV / EBITDA1.1×
Profitability
Gross margin-202.3%
Operating margin-575.3%
Net margin-638.5%
FCF margin-461.9%
Returns
ROE-102.4%
ROA-71.4%
ROIC—
Growth
Revenue growth (YoY)—
5-yr fwd EPS growth—
Financial strength
Debt / Equity—
Current ratio1.30×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.